CSM Advisors, LLC

Position in PFE — Pfizer Inc

CIK 1863523 WARRENDALE, PA

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,417,618

+$778 QoQ

Shares Held

889,436

+16.6% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#275

of 2,821 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 70% Shared 0% None 30%

Healthcare · as of Jun 30, 2026

CSM Advisors, LLC holds $167,508,675 across 11 Drug Manufacturers - General names. PFE ranks #4 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	219,688	$55,794,161
2	ABBV	AbbVie Inc.	143,403	$36,085,930
3	LLY	ELI LILLY & Co	27,478	$32,957,940
4	PFE	Pfizer Inc This page	889,436	$21,417,618
5	SNY	Sanofi	360,443	$15,376,498
6	NVS	Novartis AG	11,160	$1,748,995
7	MRK	Merck & Co., Inc.	10,162	$1,305,817
8	GILD	Gilead Sciences, Inc.	9,282	$1,172,687

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,417,618	889,436	+16.6%	Shares	Sole	2026-08-14
2026-03-31	$21,416,840	762,708	-13.4%	Shares	Sole	2026-05-15
2025-12-31	$21,942,029	881,206	+31.5%	Shares	Sole	2026-02-11
2025-09-30	$17,072,262	670,026	-21.7%	Shares	Sole	2025-11-14
2025-06-30	$20,734,411	855,380	+8567.3%	Shares	Sole	2025-08-07
2023-06-30	$361,994	9,869	-4.8%	Shares	Sole	2023-08-14
2023-03-31	$423,055	10,369	0.0%	Shares	Sole	2023-05-15
2022-12-31	$531,307	10,369	0.0%	Shares	Sole	2023-02-14
2022-09-30	$453,747	10,369	0.0%	Shares	Sole	2022-11-14
2022-06-30	$543,646	10,369	0.0%	Shares	Sole	2022-08-11
2022-03-31	$536,803	10,369	0.0%	Shares	Sole	2022-05-16
2021-12-31	$612,289	10,369	0.0%	Shares	Sole	2022-02-09
2021-09-30	$445,970	10,369	0.0%	Shares	Sole	2021-11-15
2021-06-30	$406,050	10,369	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.